02.03.20: Roadshow Edinburgh, Scotland
Roadshow Edinburgh, ScotlandLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - March 1, 2020 Category: Pharmaceuticals Source Type: news
25.02.21: Annual Report 2020
Annual Report 2020Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 27, 2020 Category: Pharmaceuticals Source Type: news
27.04.21: Annual StockholdersÂ’ Meeting 2021
Annual StockholdersÂ’ Meeting 2021Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 27, 2020 Category: Pharmaceuticals Source Type: news
12.05.21: Q1 2021 Quarterly Statement
Q1 2021 Quarterly StatementLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 27, 2020 Category: Pharmaceuticals Source Type: news
27.02.20: Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence procedures
Bayer reaches agreement with stockholder Prof. Strenger on voluntary special audit of due diligence proceduresmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 27, 2020 Category: Pharmaceuticals Source Type: news
27.02.20: Bank of America Merrill Lynch Global Agriculture and Materials Conference 2020, Fort Lauderdale, U.S.A.
Bank of America Merrill Lynch Global Agriculture and Materials Conference 2020, Fort Lauderdale, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 26, 2020 Category: Pharmaceuticals Source Type: news
27.02.20: Fiscal 2019:
Bayer strategically and operationally successfulGroup sales advance by 3.5 percent (Fx & portfolio adj.) to 43.545 billion euros / EBITDA before special items increases by 28.3 percent to 11.503 billion euros / Core earnings per share up by 14.3 percent to 6.40 euros / Net income rises 141.4 percent to 4.091 billion euros - gain of 1.637 billion euros on sale of Currenta stake / Free cash flow of 4.214 billion euros above expectations / Proposed dividend of 2.80 euros per share / Crop Science shows solid performance in challenging environment, substantial increase in earnings due to acquired business / Pharmaceuticals show...
Source: Bayer IR Newsfeed: Events - February 26, 2020 Category: Pharmaceuticals Source Type: news
26.02.20: Personnel changes after Annual Stockholders' Meeting on April 28, 2020:
Norbert Winkeljohann to succeed Werner Wenning as Chairman of Bayer's Supervisory BoardWerner Wenning to retire after over 50 years with Bayer / Horst Baier proposed for election as new shareholder representativemehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 26, 2020 Category: Pharmaceuticals Source Type: news
17.02.20: Bayer to swiftly appeal jury decision in dicamba case
Bayer to swiftly appeal jury decision in dicamba casemehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 17, 2020 Category: Pharmaceuticals Source Type: news
27.02.20: FY/Q4 2019 Investor Conference Call
FY/Q4 2019 Investor Conference CallLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 14, 2020 Category: Pharmaceuticals Source Type: news
27.02.20: Financial News Conference Full Year 2019 results
Financial News Conference Full Year 2019 resultsLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 14, 2020 Category: Pharmaceuticals Source Type: news
13.02.20: Bayer Driving Agricultural Innovation and Sustainability with Industry-Leading Pipeline and Investment
Bayer Driving Agricultural Innovation and Sustainability with Industry-Leading Pipeline and InvestmentNew herbicide molecule in early development announced; first new post-emergence mode of action for broad acre weed control in 30 years / Bayer unveils a third pathway to breakthrough short stature corn through gene editing; two prior concepts advance to Phase 3 / Three generations of herbicide-tolerance traits in soybeans advance phases, representing the industry's most robust pipeline of weed control biotechnology for soy / Largest agricultural industry R&D investment of more than 2.3 billion euros annuallymehr ... (Sourc...
Source: Bayer IR Newsfeed: Events - February 14, 2020 Category: Pharmaceuticals Source Type: news
10.02.20: Not intended for U.S. and UK Media
Bayer announces Phase III trials with new aflibercept 8mg formulationmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 10, 2020 Category: Pharmaceuticals Source Type: news
10.02.20: Start of Quiet Period
Start of Quiet PeriodLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - February 9, 2020 Category: Pharmaceuticals Source Type: news
31.01.20: Bayer Welcomes U.S. Environmental Protection Agency's Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic
Bayer Welcomes U.S. Environmental Protection Agency's Reaffirmation that Glyphosate Is Safe to Use, Not Carcinogenic"Decision of EPA corresponds to the long-standing assessments of leading international health authorities", says Liam Condon, Bayer Board Member / The Amicus brief of the U.S. Department of Justice in the Hardeman case also support Glyphosate's safetymehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - January 31, 2020 Category: Pharmaceuticals Source Type: news
